ArticleResearch (Washington, D.C.)2025

Daurisoline Modulates the TBK1-Dependent Type I Interferon Pathway to Boost Anti-tumor Immunity via Targeting of LRP1.

Borui Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.